Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Auster Insider Profile
4 Followers
Martin Auster, CFO at Ventyx Biosciences, holds 24.30K shares in Ventyx Biosciences (Ticker: VTYX). Most recently, Martin Auster Sold $1,405 shares of Ventyx Biosciences on Apr 03, 2024 for an estimated value of 7.59K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+78.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Martin Auster holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 06, 2022 - Dec 06, 2023
Return:+92.00%
The most profitable trade made by Martin Auster
Martin Auster's Trading History
List of latest transactions for each holding click on a transaction to see Martin Auster's performance on stock
You May Also Like
Martin Auster insider profile FAQ
What is the percentage of profitable transactions made by Martin Auster?
The percentage of profitable transactions made by Martin Auster is 100%.
What is the average return per transaction made by Martin Auster?
The average return per transaction made by Martin Auster is 78.10%.
What stocks does Martin Auster hold?
Martin Auster holds: VTYX stocks.
What was Martin Auster’s latest transaction?
Martin Auster latest transaction was an Informative Sell of $7.59K.
What was Martin Auster's most profitable transaction?
Martin Auster’s most profitable transaction was an Informative Sell of VTYX stock on December 6, 2022. The return on the trade was 92.00%.
What is Martin Auster's role in Ventyx Biosciences?
Martin Auster's role in Ventyx Biosciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.